These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9124210

  • 21. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.
    Cesarman E, Chadburn A, Liu YF, Migliazza A, Dalla-Favera R, Knowles DM.
    Blood; 1998 Oct 01; 92(7):2294-302. PubMed ID: 9746767
    [Abstract] [Full Text] [Related]

  • 22. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [Abstract] [Full Text] [Related]

  • 23. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.
    Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES.
    Blood; 2000 Jul 15; 96(2):443-51. PubMed ID: 10887104
    [Abstract] [Full Text] [Related]

  • 24. Senile EBV-associated B-cell lymphoproliferative disorder of indolent clinical phenotype with recurrence as aggressive lymphoma.
    Shiozawa E, Saito B, Yamochi-Onizuka T, Makino R, Takimoto M, Nakamaki T, Tomoyasu S, Ota H.
    Pathol Int; 2007 Oct 15; 57(10):688-93. PubMed ID: 17803658
    [Abstract] [Full Text] [Related]

  • 25. [Clinicopathologic study of post-transplant lymphoproliferative disorders].
    Zhang YN, Zhou XG, Wang CZ, Wei P, Zhang SH, Zheng YY.
    Zhonghua Bing Li Xue Za Zhi; 2006 Apr 15; 35(4):209-12. PubMed ID: 16776977
    [Abstract] [Full Text] [Related]

  • 26. Histologically discordant lymphomas with B-cell and T-cell components.
    Abruzzo LV, Griffith LM, Nandedkar M, Aguilera NS, Taubenberger JK, Raffeld M, Stass SA, Abbondanzo SL, Jaffe ES.
    Am J Clin Pathol; 1997 Sep 15; 108(3):316-23. PubMed ID: 9291461
    [Abstract] [Full Text] [Related]

  • 27. Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin.
    Chadburn A, Suciu-Foca N, Cesarman E, Reed E, Michler RE, Knowles DM.
    Am J Pathol; 1995 Dec 15; 147(6):1862-70. PubMed ID: 7495309
    [Abstract] [Full Text] [Related]

  • 28. Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas.
    Coad JE, Olson DJ, Christensen DR, Lander TA, Chibbar R, McGlennen RC, Brunning RD.
    Am J Surg Pathol; 1997 Sep 15; 21(9):1047-56. PubMed ID: 9298881
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clonality of primary pulmonary lymphoproliferative disorders; using in situ hybridization and polymerase chain reaction for immunoglobulin.
    Tashiro K, Ohshima K, Suzumiya J, Yoneda S, Yahiro M, Sugihara M, Shirakusa T, Kikuchi M.
    Leuk Lymphoma; 1999 Dec 15; 36(1-2):157-67. PubMed ID: 10613461
    [Abstract] [Full Text] [Related]

  • 35. Depletion of EBV-infected cells in donor marrow by counterflow elutriation.
    Gross TG, Hinrichs SH, Davis JR, Mitchell D, Bishop MR, Wagner JE.
    Exp Hematol; 1998 May 15; 26(5):395-9. PubMed ID: 9590655
    [Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus--determined clonality in posttransplant lymphoproliferative disease.
    Patton DF, Wilkowski CW, Hanson CA, Shapiro R, Gajl-Peczalska KJ, Filipovich AH, McClain KL.
    Transplantation; 1990 Jun 15; 49(6):1080-4. PubMed ID: 2163133
    [Abstract] [Full Text] [Related]

  • 37. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker MO, Gandjbakhch I, Suberbielle C, Farcet JP.
    Transplantation; 1994 Aug 15; 58(3):317-24. PubMed ID: 8053055
    [Abstract] [Full Text] [Related]

  • 38. Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes.
    Emanuel DJ, Lucas KG, Mallory GB, Edwards-Brown MK, Pollok KE, Conrad PD, Robertson KA, Smith FO.
    Transplantation; 1997 Jun 15; 63(11):1691-4. PubMed ID: 9197369
    [Abstract] [Full Text] [Related]

  • 39. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
    Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D, Kimura Y, Takeuchi M, Yoshida M, Ishibashi Y, Nakashima S, Sugita Y, Miura O, Ohshima K.
    Eur J Haematol; 2013 Jul 15; 91(1):20-8. PubMed ID: 23560463
    [Abstract] [Full Text] [Related]

  • 40. Oral presentation of posttransplantation lymphoproliferative disorders. An unusual manifestation.
    Oda D, Persson GR, Haigh WG, Sabath DE, Penn I, Aziz S.
    Transplantation; 1996 Feb 15; 61(3):435-40. PubMed ID: 8610357
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.